Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

计划入组 400 人 · 首次发布于 2006 年 4 月 3 日

Ebola and Marburg Virus Vaccines

计划入组 20 人 · 首次发布于 2008 年 1 月 31 日

Safety Trial of Monovalent Whole Virus Influenza (H1N1) Vaccine

计划入组 48 人 · 首次发布于 2012 年 1 月 11 日

inactivated whole virus vaccine

dengue virus vaccines

Zika virus eVLP vaccine (VBI Vaccines)

Whole Foods Market, Inc.

United States

WHOLE HEALTH STUDIO PTY LTD

Australia

VBI Vaccines Inc

Canada

AI-Powered Discovery Identifies Novel Monkeypox Virus Drug Target OPG153

Saint Louis University Launches Phase 1 Trial for Investigational West Nile Virus Vaccine

HHS Terminates $500 Million in Federal mRNA Vaccine Research Funding Under Kennedy Leadership